Clarification regarding approval of TAVI /TAVR Implant procedure and IVL (Coronary Intra vascular Lithotripsy) / Shock wave Lithotripsy, under CGHS
The Directorate of Central Government Health Scheme (CGHS) in India issued an Office Memorandum (OM) on December 27, 2023, regarding the approval of Transcatheter Aortic Valve Implantation/Replacement (TAVI/TAVR) and Intra Vascular Lithotripsy (IVL) or Shock Wave Lithotripsy under CGHS. The memorandum emphasizes that approval from the Director, CGHS, in consultation with the Special Technical Committee (STC), is necessary for these procedures.
No: 8108208 File No: S-11011/27/2021/CGHS(HEC)
File Name: Clarification on CGHS Package rates
Government of India
Ministry of Health & Family Welfare
Directorate of Central Government
Health Scheme (CGHS)
Hospital Empanelment Cell (HEC)
New Delhi-110066
Dated 27th December 2023
Office Memorandum
Subject: Clarification regarding approval of TAVI /TAVR Implant procedure and IVL (Coronary Intra vascular Lithotripsy) / Shock wave Lithotripsy, under CGHS
With reference to the above subject attention is drawn to the Office memorandum No. Z15025/32/2023/DIR/CGHS dated 19th December 2023 vide which CGHS package rates have been defined for TAVI/TAVR and IVL (Coronary Intra vascular Lithotripsy) / Shock wave Lithotripsy and to clarify that approval of Director, CGHS in consultation with Special Technical Committee (STC) is required for the above procedures, till further orders, as the process of formulation of guidelines is under consideration.
The Additional Directors, CGHS are advised to bring the contents of this OM to the notice of all empanelled HCOs
(Dr. Manoj Jain)
Director, CGHS
Source Document PDF